Ricki L Colman

Title: Innovations by Ricki L Colman in Glucoregulatory Dysfunction

Introduction

Ricki L Colman is an accomplished inventor based in Cross Plains, WI (US). He has made significant contributions to the field of glucoregulatory dysfunction through his innovative research and patented methods. His work focuses on identifying individuals at risk for glucoregulatory dysfunction, which is crucial for developing effective therapeutic interventions.

Latest Patents

Ricki L Colman holds a patent titled "Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations." This patent provides reagents, methods, and biochemical markers for identifying individuals with glucoregulatory dysfunction. Specifically, it outlines methods for identifying a subject based on changes in fasting blood lipid concentrations, including diacylglycerols. This innovation is vital for early detection and intervention in individuals at risk.

Career Highlights

Colman is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research. His work has garnered attention for its potential impact on public health, particularly in managing conditions related to glucoregulatory dysfunction.

Collaborations

Ricki L Colman has collaborated with notable colleagues, including Rozalyn M Anderson and Dhanansayan Shanmuganayagam. These partnerships have enhanced the scope and depth of his research, contributing to the development of innovative solutions in the field.

Conclusion

Ricki L Colman's contributions to the understanding and management of glucoregulatory dysfunction through his patented methods highlight the importance of innovation in healthcare. His work not only aids in identifying at-risk individuals but also paves the way for therapeutic advancements.